Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
- PMID: 10581028
- DOI: 10.1038/70532
Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
Abstract
At least eight inherited human neurodegenerative diseases are caused by expansion of a polyglutamine domain within the respective proteins. This confers dominant toxicity on the proteins, leading to dysfunction and loss of neurons. Expanded polyglutamine proteins form aggregates, including nuclear inclusions (NI), within neurons, possibly due to misfolding of the proteins. NI are ubiquitinated and sequester molecular chaperone proteins and proteasome components, suggesting that disease pathogenesis includes activation of cellular stress pathways to help refold, disaggregate or degrade the mutant disease proteins. Overexpression of specific chaperone proteins reduces polyglutamine aggregation in transfected cells, but whether this alters toxicity is unknown. Using a Drosophila melanogaster model of polyglutamine disease, we show that directed expression of the molecular chaperone HSP70 suppresses polyglutamine-induced neurodegeneration in vivo. Suppression by HSP70 occurred without a visible effect on NI formation, indicating that polyglutamine toxicity can be dissociated from formation of large aggregates. Our studies indicate that HSP70 or related molecular chaperones may provide a means of treating these and other neurodegenerative diseases associated with abnormal protein conformation and toxicity.
Similar articles
-
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.Mol Cell. 2005 Apr 1;18(1):37-48. doi: 10.1016/j.molcel.2005.02.030. Mol Cell. 2005. PMID: 15808507
-
A genetic model for human polyglutamine-repeat disease in Drosophila melanogaster.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1057-60. doi: 10.1098/rstb.1999.0458. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434305 Free PMC article.
-
Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice.Hum Mol Genet. 2001 Jul 1;10(14):1511-8. doi: 10.1093/hmg/10.14.1511. Hum Mol Genet. 2001. PMID: 11448943
-
Progress in pathogenesis studies of spinocerebellar ataxia type 1.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.
-
[Mechanisms to control degradation of polyglutamine-containing protein].Rinsho Shinkeigaku. 2003 Nov;43(11):906-8. Rinsho Shinkeigaku. 2003. PMID: 15152500 Review. Japanese.
Cited by
-
Aqueous Extract of Paeonia lactiflora and Paeoniflorin as Aggregation Reducers Targeting Chaperones in Cell Models of Spinocerebellar Ataxia 3.Evid Based Complement Alternat Med. 2013;2013:471659. doi: 10.1155/2013/471659. Epub 2013 Feb 25. Evid Based Complement Alternat Med. 2013. PMID: 23533486 Free PMC article.
-
Two novel DnaJ chaperone proteins CG5001 and P58IPK regulate the pathogenicity of Huntington's disease related aggregates.Sci Rep. 2024 Sep 6;14(1):20867. doi: 10.1038/s41598-024-71065-3. Sci Rep. 2024. PMID: 39242711 Free PMC article.
-
Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways.J Clin Invest. 2005 Oct;115(10):2633-9. doi: 10.1172/JCI26471. J Clin Invest. 2005. PMID: 16200196 Free PMC article. Review.
-
Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila.Genetics. 2002 Jul;161(3):1197-208. doi: 10.1093/genetics/161.3.1197. Genetics. 2002. PMID: 12136022 Free PMC article.
-
Pharmacological targeting of the Hsp70 chaperone.Curr Top Med Chem. 2009;9(15):1337-51. doi: 10.2174/156802609789895674. Curr Top Med Chem. 2009. PMID: 19860737 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
